HighTower Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.3M | Buy |
64,650
+5,725
| +10% | +$3.9M | 0.04% | 433 |
|
|
2026
Q1 | $45.5M | Buy |
58,925
+12,838
| +28% | +$9.83M | 0.05% | 380 |
|
|
2025
Q4 | $35.6M | Buy |
46,087
+356
| +0.8% | +$242K | 0.04% | 440 |
|
|
2025
Q3 | $25.7M | Buy |
45,731
+1,944
| +4% | +$1.1M | 0.03% | 522 |
|
|
2025
Q2 | $23M | Buy |
43,787
+12,514
| +40% | +$6.98M | 0.03% | 532 |
|
|
2025
Q1 | $19.8M | Buy |
31,273
+971
| +3% | +$668K | 0.03% | 541 |
|
|
2024
Q4 | $21.6M | Sell |
30,302
-2,723
| -8% | -$2.29M | 0.03% | 502 |
|
|
2024
Q3 | $34.6M | Sell |
33,025
-2,351
| -7% | -$2.62M | 0.05% | 367 |
|
|
2024
Q2 | $37.1M | Buy |
35,376
+1,204
| +4% | +$1.17M | 0.06% | 336 |
|
|
2024
Q1 | $33.1M | Sell |
34,172
-409
| -1% | -$389K | 0.05% | 351 |
|
|
2023
Q4 | $30.6M | Sell |
34,581
-606
| -2% | -$499K | 0.05% | 357 |
|
|
2023
Q3 | $28.9M | Buy |
35,187
+818
| +2% | +$643K | 0.05% | 341 |
|
|
2023
Q2 | $24.7M | Buy |
34,369
+8,751
| +34% | +$6.75M | 0.05% | 364 |
|
|
2023
Q1 | $21M | Sell |
25,618
-5,140
| -17% | -$3.88M | 0.05% | 390 |
|
|
2022
Q4 | $22.1M | Buy |
30,758
+3,125
| +11% | +$2.31M | 0.05% | 367 |
|
|
2022
Q3 | $19M | Buy |
27,633
+1,361
| +5% | +$857K | 0.05% | 351 |
|
|
2022
Q2 | $15.6M | Sell |
26,272
-2,907
| -10% | -$1.89M | 0.04% | 417 |
|
|
2022
Q1 | $20.3M | Sell |
29,179
-611
| -2% | -$387K | 0.05% | 375 |
|
|
2021
Q4 | $18.8M | Buy |
29,790
+7,908
| +36% | +$4.86M | 0.04% | 398 |
|
|
2021
Q3 | $13.2M | Buy |
21,882
+1,363
| +7% | +$846K | 0.04% | 435 |
|
|
2021
Q2 | $11.5M | Buy |
20,519
+14,383
| +234% | +$7.29M | 0.03% | 466 |
|
|
2021
Q1 | $2.9M | Sell |
6,136
-4,747
| -44% | -$2.31M | 0.01% | 945 |
|
|
2020
Q4 | $5.21M | Buy |
10,883
+538
| +5% | +$290K | 0.02% | 576 |
|
|
2020
Q3 | $5.79M | Sell |
10,345
-1,137
| -10% | -$689K | 0.03% | 503 |
|
|
2020
Q2 | $7.12M | Sell |
11,482
-449
| -4% | -$255K | 0.04% | 413 |
|
|
2020
Q1 | $5.76M | Sell |
11,931
-1,227
| -9% | -$506K | 0.04% | 408 |
|
|
2019
Q4 | $5M | Buy |
13,158
+3,083
| +31% | +$1.04M | 0.03% | 542 |
|
|
2019
Q3 | $2.79M | Buy |
10,075
+59
| +0.6% | +$17.5K | 0.02% | 772 |
|
|
2019
Q2 | $3.16M | Sell |
10,016
-8,840
| -47% | -$2.94M | 0.02% | 729 |
|
|
2019
Q1 | $7.71M | Buy |
18,856
+5,575
| +42% | +$2.3M | 0.05% | 366 |
|
|
2018
Q4 | $4.94M | Sell |
13,281
-15,699
| -54% | -$5.75M | 0.04% | 456 |
|
|
2018
Q3 | $11.7M | Buy |
28,980
+10,223
| +55% | +$3.89M | 0.08% | 264 |
|
|
2018
Q2 | $6.42M | Buy |
18,757
+6,363
| +51% | +$1.99M | 0.05% | 415 |
|
|
2018
Q1 | $4.25M | Buy |
12,394
+2,426
| +24% | +$844K | 0.04% | 520 |
|
|
2017
Q4 | $3.78M | Sell |
9,968
-1,092
| -10% | -$442K | 0.03% | 588 |
|
|
2017
Q3 | $4.95M | Buy |
11,060
+2,457
| +29% | +$1.17M | 0.04% | 465 |
|
|
2017
Q2 | $4.17M | Buy |
8,603
+1,085
| +14% | +$475K | 0.04% | 520 |
|
|
2017
Q1 | $2.92M | Buy |
7,518
+2,625
| +54% | +$973K | 0.03% | 619 |
|
|
2016
Q4 | $1.8M | Buy |
4,893
+698
| +17% | +$265K | 0.02% | 740 |
|
|
2016
Q3 | $1.68M | Buy |
4,195
+863
| +26% | +$346K | 0.02% | 722 |
|
|
2016
Q2 | $1.16M | Sell |
3,332
-5,719
| -63% | -$2.2M | 0.01% | 811 |
|
|
2016
Q1 | $3.27M | Sell |
9,051
-7,387
| -45% | -$3.04M | 0.01% | 529 |
|
|
2015
Q4 | $8.93M | Buy |
16,438
+4,815
| +41% | +$2.61M | 0.11% | 202 |
|
|
2015
Q3 | $5.41M | Buy |
11,623
+1,087
| +10% | +$584K | 0.07% | 301 |
|
|
2015
Q2 | $5.38M | Buy |
10,536
+3,787
| +56% | +$1.85M | 0.09% | 254 |
|
|
2015
Q1 | $3.05M | Buy |
6,749
+542
| +9% | +$230K | 0.05% | 454 |
|
|
2014
Q4 | $2.55M | Buy |
6,207
+167
| +3% | +$65.7K | 0.04% | 505 |
|
|
2014
Q3 | $2.18M | Buy |
6,040
+1,144
| +23% | +$383K | 0.04% | 524 |
|
|
2014
Q2 | $1.38M | Buy |
4,896
+187
| +4% | +$55.4K | 0.02% | 688 |
|
|
2014
Q1 | $1.41M | Buy |
4,709
+1,076
| +30% | +$332K | 0.03% | 626 |
|
|
2013
Q4 | $1M | Buy |
+3,633
| New | +$1.04M | 0.02% | 696 |
|
Other funds holding REGN
HighTower Advisors's REGN Position: Q2 2026 in Review
HighTower Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 9.7% in Q2 2026, buying an estimated $3.9M and bringing the position to 64,650 shares worth $40.3M. The position accounts for 0.04% of the portfolio, ranked #433.
HighTower Advisors first reported a position in REGN in Q4 2013 and has held it in 51 quarters since. The position peaked at $45.5M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- HighTower Advisors held 64,650 shares of Regeneron Pharmaceuticals worth $40.3M as of Q2 2026.
- HighTower Advisors bought 5,725 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.9M.
- Regeneron Pharmaceuticals made up 0.04% of HighTower Advisors's portfolio in Q2 2026, its #433 holding.
- HighTower Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- HighTower Advisors's Regeneron Pharmaceuticals position peaked at $45.5M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.